Clinical Trials Logo

Clinical Trial Summary

This study will evaluate the effects of a high-fat meal (food effect) on the bioavailability and pharmacokinetics of 60mg ER Torsemide tablet after single dose oral administration in healthy volunteers. The study will be conducted as a two-sequence to period crossover study to compare 60mg ER Torsemide ER bioavailability under fed and fasting conditions. 60mg ER torsemide is a new strength and dosage form.


Clinical Trial Description

Immediate Release (IR) Torsemide is a highly effective natriuretic drug but its short duration of action is a major drawback, which allows significant post-dose sodium retention, and as consequence, limits salt loss in patients with heart failure unless dietary salt intake is severely restricted. Extended Release (ER) torsemide is being developed to address this drawback by prolonging the duration of action to increase sodium excretion even in patients who consume high salt diet. Since 60mg ER torsemide is a new strength and dosage form, this study will test 60mg ER torsemide for a food effect in healthy volunteers who are either fasting or consuming a high-fat meal (fed). The primary endpoint of the study is full pharmacokinetics measurements after a single dose of 60mg ER torsemide. The secondary endpoints are 24h sodium excretion and total urinary excretion. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03215875
Study type Interventional
Source Sarfez Pharmaceuticals, Inc.
Contact
Status Completed
Phase Phase 1
Start date October 17, 2017
Completion date March 31, 2018

See also
  Status Clinical Trial Phase
Completed NCT05533788 - ABSK091 Food Effect Study in Healthy Subjects Phase 1
Completed NCT04645940 - Fruquintinib Food Effect and Proton Pump Inhibitor Study Phase 1
Completed NCT03205787 - Red Clover Botanical Dietary Supplements - Metabolism and Safety in Women N/A
Completed NCT01526213 - Do Furanocoumarins Mediate the Fexofenadine-grapefruit Juice Interaction? N/A
Completed NCT06211283 - Bioavailability and Food Effect of Sodium Valproate Minitablets in Healthy Subjects. Phase 1
Completed NCT04303039 - Study to Investigate the Effects of Food on Relative Bioavailability of ABP-671 Tablets in Healthy Subjects Phase 1
Completed NCT04397445 - Clinical Study to Investigate the Urinary Excretion of N-nitrosodimethylamine (NDMA) After Ranitidine Administration Phase 1
Completed NCT04374981 - Effect of Pineapple Juice on the Pharmacokinetics of Celecoxib and Montelukast in Humans Phase 2
Completed NCT04668274 - JOTROL PK, Safety, and Food Effect Assessment Phase 1
Completed NCT03442621 - Relacorilant Food Effect Study in Healthy Subjects Phase 1
Completed NCT05278845 - Crossover Study to Evaluate the Effect of Food on the Pharmacokinetics of SLC-391 in Healthy Adult Subjects Phase 1
Recruiting NCT04673474 - A Food-Effect Study of Hemay022 in Healthy Participants Phase 1
Recruiting NCT06218979 - KF2022#3-trial: Effect of Tea and Cola Beverage on Absorption of Risperidone Oral Solution Phase 1
Completed NCT03948243 - Licorice Botanical Dietary Supplements - Metabolism and Safety in Women Phase 1